The advanced therapies market is maturing, with China offering faster early-stage trials, while key markets include the US, UK, France, and Germany.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The advanced therapies market is maturing, with China offering faster early-stage trials, while key markets include the US, UK, France, and Germany.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Europe
terrestrial continent located in north-western Eurasia
Related events
- Regentis expands its clinical trials across markets in Europe.
- Roivant Sciences identifies a potential market for its successful drug candidate in Europe.
- MAIA Biotechnology, Inc. is actively enrolling patients and expanding its pivotal Phase 3 clinical trials across multiple nations, including Europe, Spain, Hungary, and Portugal.
- The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.
- Breakthrough is expanding its clinical trials across Europe and receiving FDA approval for its devices.